Cyanotic Cardiomyopathy: Its Clinical Implications
International Journal of Drug Delivery Technology · 01.06.2026 · 16 (39s)
DOI: 10.25258/ijddt.16.39s.40 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 01.06.2026. Verfasst von Aryasree Biju und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cardiomyopathy cyanotic is a condition characterized by progressive myocardial disease occurring as a consequence of sequelae from hypoxemia, pressure overload, and remodeling in cases of cyanotic congenital heart disease, mostly Tetralogy of Fallot (TOF). Even after corrective surgery, a considerable percentage of these patients experience ventricular dysfunction, arrhythmias, and heart failure. Therefore, it becomes imperative to understand the disease pathology associated with cardiomyopathy cyanotic.
Objective
Objectives of the review include an assessment of the pathogenesis, clinical presentation, diagnosis, and impact of chronic hypoxemia on cyanotic cardiomyopathy, especially regarding myocardial protection during surgery, postoperative low cardiac output state, ventricular tachyarrhythmias, and sudden cardiac death. Other objectives will be a review of existing treatment measures and the identification of future research requirements.
Methods
The review was done through an extensive search of articles from various databases including PubMed, Google Scholar, Cochrane database, ScienceDirect, and JTCVS. Articles that had reports of ultrastructural changes in myocardium, histopathology, haemodynamics, and surgery outcome in patients with cyanotic CHD were considered. The studies involving only acyanotic CHD or absence of haemodynamic pathologies were disregarded.
Result
Hypoxia-induced stress leads to the formation of cardiomyocyte hypertrophy, disturbance in mitochondria metabolism, myocardial fibrosis, and disruption of myofibrillar organization, mainly in the RVOT area. Myocardial pathohistological examination demonstrates the existence of cardiomyocyte hypertrophy or myocytolysis, combined with endocardial fibrosis and interstitial fibrosis in patients with heart surgery. Echocardiographic examination by tissue Doppler and MRI proves the presence of diastolic dysfunction, myocardial low velocities, and right ventricular dilatation even after operation. From the point of view of electrophysiological investigations, frequent ventricular arrhythmias, QRS fragmentation, and sudden death due to myocardial fibrosis are detected.
Conclusion
Cyanotic cardiomyopathy can be viewed as a multifactorial condition characterized by various heart muscle alterations due to hypoxia, ventricular hypertrophy, and surgery. It is necessary to perform surgical interventions at the earliest possible time while taking care of heart muscle protection in the operating theatre with cold cardioplegia in addition to life-long monitoring after surgery.
Zitieren
APA
Biju, A., Chowdhury, U. K., Dubey, P., ., M., & ., R. (2026). Cyanotic Cardiomyopathy: Its Clinical Implications. International Journal of Drug Delivery Technology, 16(39s). https://doi.org/10.25258/ijddt.16.39s.40
Vancouver
Biju A, Chowdhury UK, Dubey P, . M, . R. Cyanotic Cardiomyopathy: Its Clinical Implications. International Journal of Drug Delivery Technology. 2026;16(39s). doi:10.25258/ijddt.16.39s.40
BibTeX
@article{Biju2026,
author = {Biju, Aryasree and Chowdhury, Ujjwal Kumar and Dubey, Priya and ., Mehak and ., Rachna},
title = {Cyanotic Cardiomyopathy: Its Clinical Implications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {39s},
doi = {10.25258/ijddt.16.39s.40}
}
EUVIMED